Wikidata

(Q33348726)

English

Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer

scientific article

In more languages

Statements

title
Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12829668
retrieved
26 July 2017
author name string
Stephen R D Johnston
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12829668
retrieved
26 July 2017
Tamas Hickish
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12829668
retrieved
26 July 2017
Stephen Houston
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12829668
retrieved
26 July 2017
Lloyd Kelland
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
12829668
retrieved
26 July 2017
Janine Salter
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
12829668
retrieved
26 July 2017
Bart Michiels
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
12829668
retrieved
26 July 2017
Juan Jose Perez-Ruixo
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
12829668
retrieved
26 July 2017
Peter Palmer
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
12829668
retrieved
26 July 2017
Angela Howes
series ordinal
11
1 reference
stated in
Europe PubMed Central
PubMed ID
12829668
retrieved
26 July 2017
page(s)
2492-2499
1 reference
stated in
Europe PubMed Central
PubMed ID
12829668
retrieved
26 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33348726&oldid=1966931258"